ANIX Logo

Anixa Biosciences, Inc. (ANIX) 

NASDAQ
Market Cap
$91.52M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
191 of 963
Rank in Industry
123 of 552

Largest Insider Buys in Sector

ANIX Stock Price History Chart

ANIX Stock Performance

About Anixa Biosciences, Inc.

Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the treatment of ovarian cancer; and the discovery and development of anti-viral drug candidates for the treatment of COVID-19 focused on inhibiting certain protein functions of the virus. Its vaccine programs comprise the development of a vaccine against triple negative breast cancer; and a preventative vaccine against ovarian cancer. The company is also developing immuno-therapy drugs against cancer. It has a collaboration agreement with MolGenie GmbH to discover and develop anti-viral drug candidates against COVID-19. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California.

Insider Activity of Anixa Biosciences, Inc.

Over the last 12 months, insiders at Anixa Biosciences, Inc. have bought $441,280 and sold $0 worth of Anixa Biosciences, Inc. stock.

On average, over the past 5 years, insiders at Anixa Biosciences, Inc. have bought $470,041 and sold $42,126 worth of stock each year.

Highest buying activity among insiders over the last 12 months: KUMAR AMIT (Chief Executive Officer) — $470,550. Titterton Lewis H jr (director) — $217,680. Baskies Arnold M (director) — $51,750.

The last purchase of 5,580 shares for transaction amount of $18,023 was made by Titterton Lewis H jr (director) on 2024‑07‑31.

List of Insider Buy and Sell Transactions, Anixa Biosciences, Inc.

2024-07-31Purchasedirector
5,580
0.0182%
$3.23$18,023+4.95%
2024-07-30Purchasedirector
21,646
0.067%
$3.06$66,237+10.78%
2024-07-26Purchasedirector
7,700
0.0239%
$3.03$23,331+4.59%
2024-07-26Purchasedirector
5,000
0.0158%
$3.09$15,450+4.59%
2024-07-25Purchasedirector
796
0.0024%
$2.81$2,237+10.38%
2024-06-14Purchasedirector
4,000
0.0128%
$2.68$10,720+20.88%
2024-06-13Purchasedirector
405
0.0013%
$2.70$1,094+15.81%
2024-06-11Purchasedirector
7,102
0.0225%
$2.66$18,891+20.23%
2024-06-10Purchasedirector
330
0.001%
$2.60$858+17.98%
2024-06-07Purchasedirector
10,738
0.0332%
$2.52$27,060+23.53%
2024-06-07PurchaseChief Executive Officer
25,000
0.0738%
$2.41$60,250+23.53%
2024-06-07PurchasePresident, COO, & CFO
6,250
0.0184%
$2.40$15,000+23.53%
2024-04-09Purchasedirector
15,009
0.0475%
$3.28$49,230-4.62%
2024-03-15PurchaseChief Executive Officer
30,000
0.0821%
$3.22$96,600-15.18%
2024-03-15Purchasedirector
10,000
0.0308%
$3.63$36,300-15.18%
2023-07-31SaleChief Executive Officer
11,800
0.0371%
$3.57$42,126-7.10%
2023-07-20PurchasePresident, COO & CFO
5,500
0.0178%
$3.64$20,020-7.97%
2022-04-26Purchase
10,000
0.0345%
$2.79$27,900+58.58%
2022-04-21PurchasePresident
5,500
0.019%
$2.66$14,630+66.67%
2022-04-20PurchasePresident
2,509
0.0083%
$2.53$6,348+65.88%

Insider Historical Profitability

5.66%
Titterton Lewis H jrdirector
896334
2.7854%
$2.84671+4.15%
KUMAR AMITChief Executive Officer
516925
1.6064%
$2.84531+9.95%
Baskies Arnold Mdirector
115000
0.3574%
$2.84100<0.0001%
Catelani MichaelPresident, COO, & CFO
35211
0.1094%
$2.8450+42.61%
KRUSOS DENIS AChief Executive Officer
1969880
6.1215%
$2.84100%
Stender TishaChief Operating Officer
800000
2.4861%
$2.8410<0.0001%
JOHNSON BRUCE Fdirector
419119
1.3024%
$2.84680+8.83%
LAROUNIS GEORGE Pdirector
320000
0.9944%
$2.84100%
Roop John H.Sr. Vice President-Engineering
129500
0.4024%
$2.8430<0.0001%
BERMAN ROBERT ANDREWPresident & CEO
61553
0.1913%
$2.84260+9.15%
MONAHAN JOHN Jdirector
50900
0.1582%
$2.8410<0.0001%
Gottschalk Emilydirector
45665
0.1419%
$2.8430<0.0001%
WILLIAMS RICHARD Hdirector
25000
0.0777%
$2.8401
HERMS HENRY PV.P., Finance & CFO
22125
0.0688%
$2.841150%
Cavalier Daviddirector
2000
0.0062%
$2.8410<0.0001%
DISANTO FRANK JPresident
0
0%
$2.84010

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
The Vanguard Group$4.35M4.351.39M0%+$0<0.0001
Laird Norton Trust Company Llc$1.89M1.89604,235+63.82%+$734,447.920.22
UBS$1.67M1.68536,307-7.63%-$138,125.53<0.0001
Mission Wealth$1.57M1.57502,420+0.25%+$3,906.240.04
Susquehanna International Group$1.06M1.07340,951+365.13%+$835,061.67<0.01
Geode Capital Management$999,111.001320,148+2.46%+$23,955.10<0.0001
Long Focus Capital Management Llc$516,987.000.52165,7010%+$00.06
BlackRock$482,546.000.48154,662-1.36%-$6,661.21<0.0001
Jane Street Capital$380,403.000.38121,924+181.04%+$245,048.00<0.0001
Bank of America$364,772.000.37116,914+591.23%+$312,000.27<0.0001
State Street$338,520.000.34108,5000%+$0<0.0001
Qube Research & Technologies$291,230.000.2993,343+92.65%+$140,056.72<0.0001
BNY Mellon$271,597.000.2787,050-9.94%-$29,964.59<0.0001
Renaissance Technologies$215,000.000.2268,800New+$215,000.00<0.0001
Northern Trust$195,505.000.262,662+21.68%+$34,834.72<0.0001
Cambridge Investment Research Advisors Inc$128,000.000.1341,000+2.5%+$3,121.95<0.01
Citadel Advisors LLC$119,352.000.1238,254+129.13%+$67,263.81<0.0001
Ci Private Wealth Llc$116,688.000.1237,4000%+$0<0.0001
Morgan Stanley$115,864.000.1237,136+1.82%+$2,068.55<0.0001
Gemmer Asset Management LLC$109,200.000.1135,0000%+$00.01
LINSCO PRIVATE LEDGER CORP$83,279.000.0826,692-5.15%-$4,524.00<0.0001
Marshall Wace$82,280.000.0826,372+147.04%+$48,974.26<0.0001
Tyler Stone Wealth Management$65,545.000.0721,0080%+$00.03
Dimensional Fund Advisors$66,072.000.0721,1770%+$0<0.0001
Goldman Sachs$63,963.000.0620,501New+$63,963.00<0.0001
Occudo Quantitative Strategies Lp$57,888.000.0618,554New+$57,888.000.01
Raymond James Associates$55,396.000.0617,755-68.09%-$118,230.13<0.0001
Cubist Systematic Strategies$51,964.000.0516,655New+$51,964.00<0.0001
Squarepoint Ops LLC$49,599.000.0515,897New+$49,599.00<0.0001
Virtu Financial Llc$50,000.000.0516,156+47.23%+$16,040.48<0.01
KeyBank$48,391.000.0515,5100%+$0<0.0001
Dakota Wealth Management$46,800.000.0515,0000%+$0<0.01
Nations Financial Group Inc Ia Adv$46,800.000.0515,0000%+$0<0.01
Simplicity Wealth Llc$43,583.000.0413,969New+$43,583.00<0.01
International Assets Investment Management Llc$46,900.000.0414,0000%+$0<0.0001
Westside Investment Management Inc$43,368.000.0413,9000%+$00.01
Hightower Advisors$42,000.000.0413,5230%+$0<0.0001
Charles Schwab$39,889.000.0412,7850%+$0<0.0001
Advisory Services Network Llc$34,863.000.0411,174+80.98%+$15,600.05<0.01
Staley Capital Advisers, Inc.$31,200.000.0310,000New+$31,200.00<0.01
Simplex Trading Llc$28,000.000.039,051+2,989.08%+$27,093.58<0.01
Tower Research Capital$17,269.000.025,535+104.77%+$8,835.74<0.0001
PNC Financial Services$10,106.000.013,239+6.58%+$624.02<0.0001
Citigroup$6,511.000.012,087+37.3%+$1,768.92<0.0001
Ancora Advisors Llc$4,749.000.011,5220%+$0<0.0001
LAZARD ASSET MANAGEMENT LLC$3,000.00<0.011,194New+$3,000.00<0.0001
Advisor Group Holdings Inc$4,368.00<0.011,400+250%+$3,120.00<0.0001
Royal Bank of Canada$3,000.00<0.011,000-13.27%-$459.00<0.0001
Park Circle Co$1,560.00<0.015000%+$0<0.01
Wells Fargo$2,334.00<0.01748+1.22%+$28.08<0.0001
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.